Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy

S Tahri; M de Jong; C Fokkema; N Papazian; Z Kellermayer; C Den Hollander; M Vermeulen; M van Duin; P van de Woestijne; K Nasserinejad; E Saraci; M D'Agostino; F Gay; V Van der Velden; S Zweegman; NWCJ van de Donk; A Broijl; P Sonneveld; T Cupedo

doi:10.1182/blood-2022-164812

Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy

S Tahri, M de Jong, C Fokkema, N Papazian, Z Kellermayer, C Den Hollander, M Vermeulen, M van Duin, P van de Woestijne, K Nasserinejad, E Saraci, M D'Agostino, F Gay, V Van der Velden, S Zweegman, NWCJ van de Donk, A Broijl, P Sonneveld, T Cupedo

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	S17-S18
Number of pages	2
Journal	Clinical Lymphoma Myeloma & Leukemia
Volume	22
DOIs	https://doi.org/10.1182/blood-2022-164812
Publication status	Published - Aug 2022

Access to Document

10.1182/blood-2022-164812

Cite this

Tahri, S., de Jong, M., Fokkema, C., Papazian, N., Kellermayer, Z., Den Hollander, C., Vermeulen, M., van Duin, M., van de Woestijne, P., Nasserinejad, K., Saraci, E., D'Agostino, M., Gay, F., Van der Velden, V., Zweegman, S., van de Donk, NWCJ., Broijl, A., Sonneveld, P., & Cupedo, T. (2022). Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy. Clinical Lymphoma Myeloma & Leukemia, 22, S17-S18. https://doi.org/10.1182/blood-2022-164812

@article{11f9807c5fce487f90466c8278789c64,

title = "Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy",

author = "S Tahri and {de Jong}, M and C Fokkema and N Papazian and Z Kellermayer and {Den Hollander}, C and M Vermeulen and {van Duin}, M and {van de Woestijne}, P and K Nasserinejad and E Saraci and M D'Agostino and F Gay and {Van der Velden}, V and S Zweegman and {van de Donk}, NWCJ and A Broijl and P Sonneveld and T Cupedo",

year = "2022",

month = aug,

doi = "10.1182/blood-2022-164812",

language = "English",

volume = "22",

pages = "S17--S18",

journal = "Clinical Lymphoma Myeloma & Leukemia",

issn = "2152-2650",

publisher = "Elsevier Inc.",

}

Tahri, S, de Jong, M, Fokkema, C , Papazian, N, Kellermayer, Z, Den Hollander, C, Vermeulen, M, van Duin, M, van de Woestijne, P , Nasserinejad, K, Saraci, E, D'Agostino, M, Gay, F, Van der Velden, V, Zweegman, S, van de Donk, NWCJ, Broijl, A, Sonneveld, P & Cupedo, T 2022, 'Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy', Clinical Lymphoma Myeloma & Leukemia, vol. 22, pp. S17-S18. https://doi.org/10.1182/blood-2022-164812

Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy. / Tahri, S; de Jong, M; Fokkema, C et al.
In: Clinical Lymphoma Myeloma & Leukemia, Vol. 22, 08.2022, p. S17-S18.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy

AU - Tahri, S

AU - de Jong, M

AU - Fokkema, C

AU - Papazian, N

AU - Kellermayer, Z

AU - Den Hollander, C

AU - Vermeulen, M

AU - van Duin, M

AU - van de Woestijne, P

AU - Nasserinejad, K

AU - Saraci, E

AU - D'Agostino, M

AU - Gay, F

AU - Van der Velden, V

AU - Zweegman, S

AU - van de Donk, NWCJ

AU - Broijl, A

AU - Sonneveld, P

AU - Cupedo, T

PY - 2022/8

Y1 - 2022/8

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000895909200030&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1182/blood-2022-164812

DO - 10.1182/blood-2022-164812

M3 - Meeting Abstract

SN - 2152-2650

VL - 22

SP - S17-S18

JO - Clinical Lymphoma Myeloma & Leukemia

JF - Clinical Lymphoma Myeloma & Leukemia

ER -

Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy

Access to Document

Other files and links

Cite this